In large meta-analyses, a four-analyte BEV panel (Aβ42, p-tau181, synaptophysin, and miR-21) discriminated prodromal AD from controls with 92% accuracy, and p-tau181 levels predicted hippocampal atrophy while synaptophysin tracked cognitive decline [128]. The gene discussed is SYP; the disease is Alzheimer disease.